GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.

GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.

We have studied the effect of increased cholinergic tone on the GH response to growth hormone-releasing hormone (GHRH) and on GH feedback, using pyridostigmine, an acetylcholinesterase inhibitor. In six healthy male adult volunteers 120 mg oral pyridostigmine increased basal GH secretion compared to...

Full description

Bibliographic Details
Main Authors:	Ross, R, Tsagarakis, S, Grossman, A, Nhagafoong, L, Touzel, R, Rees, L, Besser, G
Format:	Journal article
Language:	English
Published:	1987

Similar Items

THE EFFECTS OF STILBESTROL PRETREATMENT ON THE GH RESPONSE TO INSULIN HYPOGLYCEMIA AND GHRH - EVIDENCE FOR A HYPOTHALAMIC SITE OF ACTION
by: Ross, R, et al.
Published: (1986)

Hypothalamic mediation of reduced GH secretion in diabetic rats: evidence for reduced cholinergic inhibition of somatostatin release
by: Ismail, I.S., et al.
Published: (1995)

Pyridostigmine enhances, but does not normalise, the GH response to GH-releasing hormone in obese subjects.
by: Castro, R, et al.
Published: (1990)

Relationship between growth hormone-releasing hormone and somatostatin in the rat: effects of age and sex on content and in-vitro release from hypothalamic explants.
by: Ge, F, et al.
Published: (1989)

Glucose-induced changes in somatostatin-14 and somatostatin-28 released from rat hypothalamic fragments 'in vitro'.
by: Lengyel, A, et al.
Published: (1984)

Subcutaneous growth hormone-releasing hormone augments pulsatile nocturnal GH release in GH-insufficient children, but may also raise basal GH secretion.
by: Ross, R, et al.
Published: (1990)

RESPONSES OF SERUM GH AND SOMATOMEDIN-C TO AN ANALOG OF GHRH IN CHILDREN WITH GROWTH-HORMONE DEFICIENCY
by: Grossman, A, et al.
Published: (1984)

Dose-dependent effects of vasoactive intestinal polypeptide on somatostatin release from hypothalamic fragments in vitro.
by: Lengyel, A, et al.
Published: (1989)

Glucose modulation of somatostatin and LHRH release from rat hypothalamic fragments in vitro.
by: Lengyel, A, et al.
Published: (1984)

Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback
by: Ismail, I.S., et al.
Published: (1993)

Pyridostigmine, an Acetylcholinesterase Inhibitor, Stimulates Growth Hormone Release, but has no Effect on Basal Thyrotrophin or Adrenocorticotrophin Levels, or the Thyrotrophin Response to Thyrotrophin-Releasing Hormone.
by: Freeman, E, et al.
Published: (1990)

Effects of dopamine and morphine on immunoreactive somatostatin and LH-releasing hormone secretion from hypothalamic fragments in vitro.
by: Lengyel, A, et al.
Published: (1985)

EFFECTS OF ACETYLCHOLINE AND NORADRENALINE ON IMMUNOREACTIVE CRF-41 RELEASE FROM INCUBATED RAT HYPOTHALAMIC FRAGMENTS INVITRO
by: Besser, G, et al.
Published: (1988)

Desensitisation of somatostatin, TRH and GHRH responses to glucose in the diabetic (Goto-Kakizaki) rat hypothalamus
by: Lewis, B.M., et al.
Published: (1996)

CHILDREN WITH IDIOPATHIC SHORT STATURE SHOW A GREATER RESPONSE TO GHRH THAN INSULIN HYPOGLYCEMIA - RESPONSE TO GHRH (1-29)NH2 IN 16 NORMAL SUBJECTS AND 55 CHILDREN WITH SHORT STATURE
by: Ross, R, et al.
Published: (1988)

IGF-I levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man.
by: Borges, M, et al.
Published: (1999)

Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone.
by: Delitala, G, et al.
Published: (1989)

[Clinical value of neuropeptides GHRH and GHRP]
by: Savage, M, et al.
Published: (1996)

Central neuroregulation of hypothalamic corticotropin-releasing hormone (CRH-41) secretion.
by: Tsagarakis, S, et al.
Published: (1990)

Studies off the opiate control of prolactin, GH and TSH.
by: Grossman, A, et al.
Published: (1981)

EVIDENCE THAT GROWTH-HORMONE INHIBITS THE GH RESPONSE TO GROWTH HORMONE-RELEASING FACTOR IN MAN
by: Ross, R, et al.
Published: (1985)

The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals.
by: Achermann, J, et al.
Published: (1999)

Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone.
by: Trainer, P, et al.
Published: (1992)

The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man.
by: Hindmarsh, P, et al.
Published: (1991)

The regulation of hypothalamic corticotropin-releasing factor release: in vitro studies.
by: Grossman, A, et al.
Published: (1993)

THE REGULATION OF HYPOTHALAMIC CORTICOTROPIN-RELEASING FACTOR RELEASE - INVITRO STUDIES
by: Grossman, A, et al.
Published: (1993)

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.
by: Chahal, H, et al.
Published: (2011)

Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up.
by: Tsagarakis, S, et al.
Published: (1991)

The participation of hypothalamic dopamine in morphine-induced prolactin release in man.
by: Delitala, G, et al.
Published: (1983)

The growth hormone releasing hormone (GHRH) response to a mixed meal is blunted in young adults with insulin-dependent diabetes mellitus whereas the somatostatin response is normal.
by: Foot, AB, et al.
Published: (1990)

ENHANCING HYPOTHALAMIC-LESIONS SHOWN ON HIGH-RESOLUTION COMPUTERIZED-TOMOGRAPHY IN PATIENTS WITH IDIOPATHIC HYPOPITUITARISM
by: Charlesworth, M, et al.
Published: (1986)

ENHANCING HYPOTHALAMIC-LESIONS SHOWN ON HIGH-RESOLUTION COMPUTERIZED-TOMOGRAPHY IN PATIENTS WITH IDIOPATHIC HYPOPITUITARISM
by: Charlesworth, M, et al.
Published: (1986)

Dopaminergic and cholinergic influences on the growth hormone response to growth hormone-releasing hormone in man.
by: Delitala, G, et al.
Published: (1987)

The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects.
by: Stafford, P, et al.
Published: (1989)

HYPOPITUITARISM IN CHILDREN - GRF-40 PROMOTES GH SECRETION AND CRF-41 ACTH-SECRETION
by: Grossman, A, et al.
Published: (1984)

Pyridostigmine-induced dystonic blepharospasm in a patient with ocular myasthenia gravis.
by: Yew, Chien Voon, et al.
Published: (2010)

Naloxone inhibits exercise-induced release of PRL and GH in athletes.
by: Moretti, C, et al.
Published: (1983)

Opiate peptides control growth hormone through a cholinergic mechanism in man.
by: Delitala, G, et al.
Published: (1983)

Interleukin-1 beta modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect.
by: Honegger, J, et al.
Published: (1991)

Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitro.
by: Tsagarakis, S, et al.
Published: (1989)